Information between 6th March 2024 - 5th May 2024
Note: This sample does not contain the most recent 2 weeks of information. Up to date samples can only be viewed by Subscribers.
Click here to view Subscription options.
Calendar |
---|
Monday 20th May 2024 Lord Hunt of Kings Heath (Labour - Life peer) Oral questions - Main Chamber Subject: Improving the awareness and services for people with inflammatory bowel disease View calendar |
Parliamentary Debates |
---|
Homecare Medicines Services (Public Services Committee Report)
22 speeches (15,020 words) Thursday 2nd May 2024 - Lords Chamber Department of Health and Social Care Mentions: 1: Lord Mott (Con - Life peer) When it works well, homecare offers people with inflammatory bowel disease the opportunity to receive - Link to Speech |
Prescription Charges: Long-term Health Conditions
11 speeches (4,445 words) Monday 11th March 2024 - Westminster Hall Department of Health and Social Care Mentions: 1: Christina Rees (LAB - Neath) a number of conditions that are not exempt from prescription charges, including MS, endometriosis, inflammatory - Link to Speech |
Select Committee Documents |
---|
Friday 26th April 2024
Written Evidence - Crohn's and Colitis UK DYE0019 - Disability employment Disability employment - Work and Pensions Committee Found: DYE0019 1.About Crohn’s and Colitis 1.1Crohn’s Disease and Ulcerative Colitis are the two main forms of Inflammatory |
Wednesday 24th April 2024
Written Evidence - HMCPS Inspectorate (retired 2010) NHL0062 - NHS leadership, performance and patient safety NHS leadership, performance and patient safety - Health and Social Care Committee Found: He provided innovative treatment for inflammatory bowel disease (ulcerative colitis) and was instrumental |
Written Answers |
---|
Inflammatory Bowel Disease: Employment and Support Allowance
Asked by: Mark Hendrick (Labour (Co-op) - Preston) Tuesday 23rd April 2024 Question to the Department for Work and Pensions: To ask the Secretary of State for Work and Pensions, how many people (a) applied for and (b) received employment and support allowance for inflammatory bowel disease in (i) Preston, (ii) Lancashire and (iii) England in each year since 2020. Answered by Mims Davies - Minister of State (Department for Work and Pensions) The information requested is not readily available and to provide it would incur disproportionate cost. |
Inflammatory Bowel Disease: Personal Independence Payment
Asked by: Mark Hendrick (Labour (Co-op) - Preston) Tuesday 23rd April 2024 Question to the Department for Work and Pensions: To ask the Secretary of State for Work and Pensions, how many people in (a) Preston, (b) Lancashire and (c) England have (i) applied for and (ii) received Personal Independence Payments for inflammatory bowel disease in each year since 2020. Answered by Mims Davies - Minister of State (Department for Work and Pensions) The latest available data on personal independence payment (PIP) clearances and awards can be found here. The requested data can be found on the ‘PIP Clearances’ dataset by going to ‘Geography’, ‘National – Regional – LAs – OAs’ and following the drop downs to the relevant areas. Similarly, you can filter for those with inflammatory bowel disease through ‘Disability’, ‘Gastrointestinal disease’ and selecting ‘Inflammatory bowel disease’. To further filter just for those awarded, you can go to ‘Clearance Type Detail’ and select ‘Awarded’.
A lookup which shows which Local Authorities are in Lancashire is available here.
Data is based on primary disabling condition as recorded on the PIP computer systems. Claimants may often have multiple disabling conditions upon which the decision is based but only the primary condition is shown in these statistics.
Guidance on how to use Stat-Xplore can be found here. An account is not required to use Stat- Xplore, the ‘Guest Login’ feature gives instant access to the main functions. |
Department Publications - Transparency |
---|
Friday 12th April 2024
Home Office Source Page: Non-technical summaries granted in 2024 Document: Non-technical summaries: projects granted in 2024, January to March (PDF) Found: bowel disease, rheumatoid arthritis, and psoriasis. |
Tuesday 19th March 2024
Ministry of Defence Source Page: FOI responses published by MOD: week commencing 18 March 2024 Document: Joining the Royal Navy with spinal surgery for Scheuremann's disease (JSP 950) (PDF) Found: Candi dates with a history of inflammatory bowel disease, including but not limited to unspeci fied |
Non-Departmental Publications - Statistics |
---|
Mar. 27 2024
Government Office for Science Source Page: Ultra-processed food (UPFs) Document: Ultra-Processed Food - PDF (PDF) Statistics Found: emulsifiers and their impact on gut microbiome, permeability, and inflammation: Mechanistic insights in inflammatory |
Non-Departmental Publications - Transparency |
---|
Mar. 14 2024
Medicines and Healthcare products Regulatory Agency Source Page: Freedom of Information responses from the MHRA - week commencing 29 May 2023 Document: FOI 23/351 - attachment 1 (PDF) Transparency Found: Another large, well designed cohort stud y found that patients with inflammatory bowel disease have |
Mar. 14 2024
Medicines and Healthcare products Regulatory Agency Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023 Document: FOI 23/774 - attachment 1 (PDF) Transparency Found: Hamed SA et al 2019 , Kitamura H et al 1988 , Careless D et al 1993 , Olbricht CJ et al 1993 ) and inflammatory |
Mar. 14 2024
Medicines and Healthcare products Regulatory Agency Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023 Document: FOI 23/879 - attachment 2 (PDF) Transparency Found: Colitis (excl infective) Colitis 4 0 Colitis ulcerative 1 0 Crohn's disease 5 0 Inflammatory |
Mar. 14 2024
Medicines and Healthcare products Regulatory Agency Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023 Document: FOI 23/857 - attachment 2 (PDF) Transparency Found: Gastrointestinal sounds abnormal 1 0 Colitis (excl infective) Crohn's disease 1 0 Inflammatory |
Mar. 14 2024
Medicines and Healthcare products Regulatory Agency Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023 Document: FOI 23/774 - attachment 2 (PDF) Transparency Found: bowel disease, Injection site mass, Intermenstrual bleeding, Intracranial pressure increased, Irritable |
Mar. 14 2024
Medicines and Healthcare products Regulatory Agency Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023 Document: FOI 23/937 - attachment 2 (PDF) Transparency Found: Colitis (excl infective) Colitis 4 0 Colitis ulcerative 1 0 Crohn's disease 5 0 Inflammatory |
Mar. 14 2024
Medicines and Healthcare products Regulatory Agency Source Page: Freedom of Information responses from the MHRA - week commencing 18 December 2023 Document: FOI 23/905 - attachment 3 (PDF) Transparency Found: Demyelination multiple sclerosis Systemic lupus erythematosus Psoriatic arthritis Psoriasis Inflammatory |
Mar. 14 2024
Medicines and Healthcare products Regulatory Agency Source Page: Freedom of Information responses from the MHRA - week commencing 18 December 2023 Document: FOI 23/905 - attachment 2 (PDF) Transparency Found: identified by diagnosis codes) Medicatio n prox ies Polymyalgia rheumatica No Psoriasis No Inflammatory |
Mar. 14 2024
Medicines and Healthcare products Regulatory Agency Source Page: Freedom of Information responses from the MHRA - week commencing 18 December 2023 Document: FOI 23/905 - attachment 4 (PDF) Transparency Found: arthritis No Sjögren's syndrome No Polymyalgia rheumatica No 26 Page 27 of 60 Psoriasis No Inflammatory |